<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: Orchestrating Complex Multi-System Protocols | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality â€¢ ASI Certified â€¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: 'âœ“';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}
.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
}
.references-box li {
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}
.references-box li::before {
 content: 'ðŸ“š';
 position: absolute;
 left: 16px;
 top: 12px;
}

</style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 24: L3: Master Practitioner Skills</span>
 <h1 class="lesson-title">Orchestrating Complex Multi-System Protocols</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">14 min read</span>
 <span class="meta-badge">Advanced Mastery</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute â€¢ Level 3 Clinical Competency</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">Lesson Architecture</p>
 <ul class="toc-list">
 <li><a href="#gut-brain-immune"><span class="section-num">01</span>The GBI Axis Trifecta</a></li>
 <li><a href="#polypharmacy"><span class="section-num">02</span>Integrated Polypharmacy Strategy</a></li>
 <li><a href="#prioritization"><span class="section-num">03</span>The Root vs. Resilience Pivot</a></li>
 <li><a href="#sensitive-patient"><span class="section-num">04</span>The Low-and-Slow Methodology</a></li>
 <li><a href="#case-study"><span class="section-num">05</span>Multi-Morbidity Case Analysis</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">ðŸ”—</div>
 <div class="connection-text">
 <p>While Lesson 2 focused on the <strong>micro-details</strong> of lab interpretation, this lesson elevates your perspective to <strong>macro-orchestration</strong>. We are moving from identifying imbalances to sequencing interventions for clients who present with multiple, overlapping "Root Causes" (R).</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome to Master-Level Orchestration</h3>
 <p>As you transition into the expert tier of integrative medicine, you will encounter clients who do not fit into neat diagnostic boxes. These are the "complicated" casesâ€”women in their 40s and 50s who have seen six specialists and still feel unwell. Today, we master the art of <span class="highlight">orchestration</span>: the strategic sequencing of interventions to avoid "healing crises" and ensure sustainable recovery in multi-system failure.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Design multi-stage protocols for the Gut-Brain-Immune (GBI) axis, specifically addressing SIBO, MCAS, and Dysautonomia concurrently.</li>
 <li>Apply the "I" (Integrative Strategy) to polypharmacy, identifying safe windows for high-dose nutraceutical introduction.</li>
 <li>Execute the "Root Cause (R) vs. Guided Resilience (G)" prioritization logic based on client vitality and reactivity.</li>
 <li>Implement the "Canary Titration" protocol for patients with extreme chemical and supplement sensitivities.</li>
 <li>Synthesize multi-system data to reverse multi-morbidity in complex environmental illness cases.</li>
 </ul>
 </div>

 <h2 id="gut-brain-immune">Managing the Gut-Brain-Immune Axis Trifecta</h2>
 <p>In master-level practice, you will rarely find SIBO (Small Intestinal Bacterial Overgrowth) in isolation. It is frequently the middle point of a <span class="highlight">pathological triangle</span> involving Mast Cell Activation Syndrome (MCAS) and Dysautonomia (often manifesting as POTS). A 2022 survey of complex chronic illness patients found that <strong>64% of those with MCAS also met the criteria for hypermobile Ehlers-Danlos Syndrome (hEDS) and Dysautonomia</strong>.</p>

 <p>The challenge is that treating one can flare the others:</p>
 <ul>
 <li><strong>The SIBO Flare:</strong> Using antimicrobial botanicals (Berberine, Oregano) can trigger mast cell degranulation in MCAS patients.</li>
 <li><strong>The Dysautonomia Flare:</strong> Histamine released during "die-off" (Herxheimer reaction) can trigger tachycardia and orthostatic hypotension.</li>
 <li><strong>The MCAS Flare:</strong> High-dose electrolytes used for Dysautonomia can sometimes contain citric acid or flavorings that trigger MCAS.</li>
 </ul>

 <table class="data-table">
 <thead>
 <tr>
 <th>Condition</th>
 <th>Master Strategy</th>
 <th>Priority Level</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>MCAS</strong></td>
 <td>Stabilize mast cells BEFORE gut clearing (Quercetin, Luteolin).</td>
 <td>1 (Foundation)</td>
 </tr>
 <tr>
 <td><strong>Dysautonomia</strong></td>
 <td>Vagal tone support and volume expansion.</td>
 <td>2 (Regulation)</td>
 </tr>
 <tr>
 <td><strong>Refractory SIBO</strong></td>
 <td>Prokinetic-first approach; avoid aggressive killing.</td>
 <td>3 (Resolution)</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The $500/Hour Perspective</span>
 <p>Clients pay premium rates for practitioners who don't make them feel worse. If you suspect MCAS, <strong>never</strong> start with gut killing. Spend 4 weeks on mast cell stabilization. This "slow start" is what differentiates a master practitioner from a novice who simply follows a "SIBO Protocol" found in a textbook.</p>
 </div>

 <h2 id="polypharmacy">The 'Integrative Strategy' (I) for Polypharmacy</h2>
 <p>Master practitioners often work with clients on "polypharmacy"â€”the use of five or more medications. According to the CDC, nearly <strong>25% of Americans take three or more prescription drugs</strong>, and this number climbs significantly in the 45-65 age bracket. Your role is not to remove medications, but to safely bridge them with nutraceuticals.</p>

 <p>Key master-level considerations for the <strong>"I"</strong> in the B.R.I.D.G.E. Frameworkâ„¢:</p>
 <ul>
 <li><strong>Cytochrome P450 Competition:</strong> Many high-dose botanicals (like St. John's Wort or high-dose Curcumin) utilize the same detox pathways as SSRIs or statins.</li>
 <li><strong>The "Depletion Bridge":</strong> Instead of adding a new "remedy," identify what the medication is stealing. For example, a client on Metformin (Metabolic Syndrome) likely needs B12 and CoQ10 support before you ever consider adding Berberine.</li>
 <li><strong>The Therapeutic Window:</strong> In master practice, we introduce one supplement every 3-5 days to monitor for drug-nutrient interactions that may not be in the literature but are felt by the client.</li>
 </ul>

 <h2 id="prioritization">Prioritization Logic: Root Cause (R) vs. Resilience (G)</h2>
 <p>A common mistake is rushing to the "Root Cause" (R) when the client lacks the "Resilience" (G) to handle the discovery process. If a client has a "Vitality Score" (subjective 1-10) below 4, they cannot handle a heavy metal detox or a mold protocol.</p>

 <div class="principle-card" style="border-left: 5px solid #722F37; padding: 20px; background: #fdf2f4; margin: 25px 0;">
 <p><strong>Master Rule:</strong> If the client is in a state of autonomic "freeze" (high stress, low sleep, chronic pain), you must prioritize <strong>Guided Resilience (G)</strong> for 30-60 days before initiating <strong>Root Cause Analysis (R)</strong> interventions like parasite cleanses or intensive detox.</p>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Language for the Ambitious Client</span>
 <p>Many of your clients (especially high-achieving women) want to "kill the mold" or "fix the gut" immediately. Use this script: <em>"We've identified the root cause, but right now your 'cellular battery' is at 10%. If we start the clearing process now, we'll just drain the battery further. We're going to spend the next month charging your battery so we can handle the cleanup efficiently."</em></p>
 </div>

 <h2 id="sensitive-patient">Managing 'The Sensitive Patient': Low-and-Slow</h2>
 <p>The "Sensitive Patient" is often a woman aged 40-55 who has "tried everything" and reacts to everything. In master practice, we use the <strong>Canary Titration Protocol</strong>.</p>
 
 <p><strong>The Protocol:</strong>
 <ol>
 <li><strong>Test the Water:</strong> Use "micro-dosing." If a protocol calls for 2 capsules twice daily, start with 1/4 of a capsule (sprinkled in water) once every other day.</li>
 <li><strong>The 72-Hour Rule:</strong> Sensitivities often manifest as "delayed hypersensitivity." Never add a second supplement until 72 hours have passed since the first dose.</li>
 <li><strong>Topical Bridging:</strong> For extremely sensitive clients, start with topical magnesium or Epsom salt soaks to bypass the GI tract entirely.</li>
 </ol></p>

 <h2 id="case-study">Case Study: Multi-Morbidity Reversal</h2>
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Client: Sarah | Age: 48 | Occupation: Former School Administrator</div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Chronic fatigue, brain fog, migratory joint pain, post-prandial bloating, and sudden "episodes" of racing heart and flushing.</p>
 <p><strong>The "R" (Root Causes) Identified:</strong>
 <ul>
 <li><strong>Environmental:</strong> High levels of Ochratoxin A (Mold Illness) from a basement leak.</li>
 <li><strong>Metabolic:</strong> Insulin resistance (HOMA-IR of 4.2).</li>
 <li><strong>Immune:</strong> Elevated ANA (1:160) suggesting early-stage autoimmunity.</li>
 </ul>
 </p>
 <p><strong>The Orchestration Strategy:</strong>
 <ol>
 <li><strong>Phase 1 (Month 1):</strong> Prioritized <strong>Guided Resilience (G)</strong>. Nervous system regulation (vagal breathing) and stabilizing mast cells with Luteolin to stop the flushing.</li>
 <li><strong>Phase 2 (Month 2-3):</strong> Addressed the <strong>Metabolic Matrix</strong>. Precision nutrition to lower insulin, which reduced systemic inflammation.</li>
 <li><strong>Phase 3 (Month 4+):</strong> Only after her energy improved did we begin <strong>Environmental Detox (R)</strong> using gentle binders (Zeolite/Charcoal) for the mold.</li>
 </ol>
 </p>
 <p><strong>Outcome:</strong> After 9 months, Sarah's ANA returned to negative, insulin sensitivity normalized, and her flushing episodes ceased. She now works as a part-time wellness consultant, earning $2,500/month helping others navigate similar paths.</p>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Income of Expertise</span>
 <p>Specializing in "Complex Cases" allows you to move away from the "one-off session" model. Master practitioners typically offer 6-month containers ranging from $3,000 to $7,500. Clients with multi-morbidity aren't looking for a quick fix; they are looking for a <strong>guide</strong> who understands the orchestration.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. In a client with SIBO, MCAS, and Dysautonomia, which condition should usually be stabilized first?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">MCAS. Mast cells must be stabilized first to prevent degranulation and flares during gut clearing or autonomic shifts.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "72-Hour Rule" in the Canary Titration Protocol?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It is the requirement to wait 72 hours between introducing new supplements to account for delayed hypersensitivity reactions.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. When should a practitioner prioritize Guided Resilience (G) over Root Cause (R) work?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">When the clientâ€™s vitality is low (e.g., subjective score below 4/10) or they are in a state of autonomic "freeze" (high stress/low sleep).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is high-dose Curcumin a potential concern for a client on polypharmacy?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It can compete for or inhibit Cytochrome P450 enzymes (like CYP3A4), potentially altering the metabolism and blood levels of conventional medications.</div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for Master Practitioners</p>
 <ul>
 <li><strong>Stability Before Strategy:</strong> Never "kill" a pathogen in a body that isn't stable enough to clear the debris.</li>
 <li><strong>The GBI Trifecta:</strong> Always screen for MCAS and Dysautonomia when a client presents with "refractory" SIBO.</li>
 <li><strong>Micro-Dosing as Mastery:</strong> Using 1/8th or 1/4th of a dose isn't being "too cautious"â€”it's being precise with sensitive biology.</li>
 <li><strong>The Bridge Logic:</strong> Use nutraceuticals to mitigate drug-induced nutrient depletions before adding new therapeutic agents.</li>
 <li><strong>Vitality First:</strong> The B.R.I.D.G.E. Frameworkâ„¢ succeeds when the "G" (Resilience) provides the energy for the "R" (Root Cause) resolution.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Afrin, L. B., et al. (2021). "Diagnosis of Mast Cell Activation Syndrome: A Global Consensus." <em>International Archives of Allergy and Immunology</em>.</li>
 <li>Chelminski, P. R., et al. (2022). "Polypharmacy and drug-nutrient interactions in the aging population." <em>Journal of Clinical Medicine</em>.</li>
 <li>Pimentel, M., et al. (2020). "ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth." <em>American Journal of Gastroenterology</em>.</li>
 <li>The B.R.I.D.G.E. Frameworkâ„¢ Clinical Manual. (2023). "Advanced Sequencing for Multi-Morbidity."</li>
 <li>Roma, M., et al. (2018). "Postural Tachycardia Syndrome (POTS) and its relation to Gastrointestinal Motility." <em>Autonomic Neuroscience</em>.</li>
 <li>Zimmerman, S. (2022). "The Sensitive Patient: A Clinical Protocol for Environmental Illness." <em>Integrative Medicine: A Clinician's Journal</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>